Nano Cap New Millennium Growth Fund L P
Source: SEC Form 13F · as of Mar 2026Nano Cap New Millennium Growth Fund L P holds 15 biotech & pharma companies tracked by BioSniper, totaling $2.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$2.9M
BioSniper AIPage context preserved
Prepared research question
What matters most for XOMA Royalty Corporation (XOMA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| XOMAXOMA Royalty Corporation | 17,000 | $533K |
| ALECAlector, Inc. | 200,000 | $430K |
| PLRXPLIANT THERAPEUTICS, INC. | 275,000 | $347K |
| PHVSPharvaris N.V. | 10,000 | $283K |
| AUTLAutolus Therapeutics plc | 150,000 | $207K |
| SPRYARS Pharmaceuticals, Inc. | 25,000 | $201K |
| DNAGinkgo Bioworks Holdings Inc. | 25,000 | $153K |
| IMAImageneBio, Inc. | 30,000 | $150K |
| INTSINTENSITY THERAPEUTICS, INC. | 25,000 | $147K |
| FENCFENNEC PHARMACEUTICALS INC. | 21,500 | $132K |
| BOLTBolt Biotherapeutics, Inc. | 27,500 | $111K |
| ORICOric Pharmaceuticals, Inc. | 7,500 | $95K |
| GPCRStructure Therapeutics Inc. | 1,500 | $72K |
| KLRSKalaris Therapeutics, Inc. | 4,000 | $23K |
| PRQRProQR Therapeutics N.V. | 10,000 | $16K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.